The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
According to the estimates by IMARC Group, the global atherectomy devices market is expected to grow at a CAGR of around 5% during 2021-2026.
The rising adoption of atherectomy devices for treating peripheral artery diseases (PADs) and coronary artery diseases (CADs) represents one of the key drivers for the global atherectomy devices market.
The growing integration of directional atherectomy with anti-restenosis therapy (DAART) to improve the patency in long lesions and lesions with severe calcifications, represents one of the major trends in the global atherectomy devices market.
Sudden outbreak of the COVID-19 pandemic had led to the cancellation or postponement of several elective cardiovascular surgeries to reduce the risk of coronavirus infection upon hospital visits.
On the basis of the product, the market has been classified into directional atherectomy devices, orbital atherectomy devices, photo-ablative atherectomy devices, rotational atherectomy devices, and support devices. Among these, directional atherectomy devices hold the majority of market share.
On the basis of the application, the market has been classified into peripheral vascular, cardiovascular, and neurovascular. Among these, peripheral vascular represents the largest segment.
On the basis of the end user, the market has been bifurcated into hospitals, ambulatory surgery centers, and research laboratories and academic institutes. Among these, hospitals dominate the market share.
Region-wise, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America dominates the global market.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at